Novo Nordisk shows Korean media its automated Wegovy 'Future Factory'
Chosun Ilbo got a look inside the plant, where AI systems and robots run much of the Wegovy production line.
Recap by typeshit. Full story at 조선일보.
Read at 조선일보
More peptides
-
A look at whether the munchies feel different for people on a GLP-1 
A look at whether the munchies feel different for people on a GLP-1
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
-
Philstar Life on celebrities and the weight loss drug Ozempic Philstar Life on celebrities and the weight loss drug Ozempic
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
-
Food and agribusiness expert says fibre is gaining ground with the GLP-1 trend 
Food and agribusiness expert says fibre is gaining ground with the GLP-1 trend
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
-
Experimental injection that makes fat cells self destruct shows early promise 
Experimental injection that makes fat cells self destruct shows early promise
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
-
Biomea shares rise 6.44% ahead of Phase I data for obesity drug BMF-650 peptides typeshitResearchBiomea shares rise 6.44% ahead of Phase I data for obesity drug BMF-650
Biomea Fusion was set to release early results for its investigational obesity candidate on October 13, with shares at $1.44 in premarket trading.
-
NexLife index puts compounded tirzepatide at a $222 median monthly price 
peptides typeshitPricesNexLife index puts compounded tirzepatide at a $222 median monthly price
Its October check of 21 US telehealth programs found compounded semaglutide at a $175 median, with a $79 sale low, counting memberships in the all-in price.